TCR2 THERAPTCS Current Ratio 2019-2018 | TCRR

TCR2 THERAPTCS current ratio from 2019 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
TCR2 THERAPTCS Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.407B $0.000B
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy company developing T cell therapies for patients suffering from cancer. Its product candidate includes TC-210, TC-220, TC-410, TC-110 and TC-310 which are in clinical stage. TCR2 Therapeutics Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $48.799B 32.43
Takeda Pharmaceutical (TAK) Japan $28.404B 10.51
Grifols (GRFS) Spain $13.029B 15.92
Ionis Pharmaceuticals (IONS) United States $10.222B 31.70
Sage Therapeutics (SAGE) United States $7.722B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.333B 10.50
Neurocrine Biosciences (NBIX) United States $7.116B 458.65
Catalent (CTLT) United States $6.500B 27.21
Nektar Therapeutics (NKTR) United States $5.533B 8.83
Tilray (TLRY) Canada $4.962B 0.00
United Therapeutics (UTHR) United States $4.461B 7.59
Taro Pharmaceutical Industries (TARO) Israel $4.241B 13.65
FibroGen (FGEN) United States $4.125B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.695B 0.00
Portola Pharmaceuticals (PTLA) United States $2.448B 0.00
PTC Therapeutics (PTCT) United States $2.256B 0.00
USANA Health Sciences (USNA) United States $1.886B 15.82
Ironwood Pharmaceuticals (IRWD) United States $1.871B 0.00
Heron Therapeutics (HRTX) United States $1.860B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.795B 0.00
Aerie Pharmaceuticals (AERI) United States $1.782B 0.00
Xencor (XNCR) United States $1.753B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.725B 21.49
Endo (ENDP) Ireland $1.661B 2.56
Pacira Pharmaceuticals (PCRX) United States $1.659B 143.54
Madrigal Pharmaceuticals (MDGL) United States $1.647B 0.00
Zogenix (ZGNX) United States $1.622B 0.00
Tricida (TCDA) United States $1.412B 0.00
Corcept Therapeutics (CORT) United States $1.387B 20.15
Theravance Biopharma (TBPH) Cayman Islands $1.319B 0.00
Esperion Therapeutics (ESPR) United States $1.160B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.045B 0.00
TherapeuticsMD (TXMD) United States $0.991B 0.00
Radius Health (RDUS) United States $0.973B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.881B 0.00
CannTrust Holdings (CTST) Canada $0.794B 0.00
Akebia Therapeutics (AKBA) United States $0.757B 0.00
ChemoCentryx (CCXI) United States $0.753B 0.00
ArQule (ARQL) United States $0.677B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.617B 0.00
Dermira (DERM) United States $0.606B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.605B 0.00
Odonate Therapeutics (ODT) United States $0.597B 0.00
Forty Seven (FTSV) United States $0.586B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.565B 0.00
GlycoMimetics (GLYC) United States $0.557B 0.00
Collegium Pharmaceutical (COLL) United States $0.486B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.467B 24.11
Corbus Pharmaceuticals Holdings (CRBP) United States $0.462B 0.00
KalVista Pharmaceuticals (KALV) United States $0.431B 0.00
Siga Technologies (SIGA) United States $0.427B 0.00
Translate Bio (TBIO) United States $0.419B 0.00
Aptorum Group (APM) China $0.419B 0.00
Flexion Therapeutics (FLXN) United States $0.410B 0.00
OptiNose (OPTN) United States $0.390B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.381B 0.00
Mast Therapeutics (SVRA) United States $0.371B 0.00
ImmunoGen (IMGN) United States $0.366B 0.00
CASI Pharmaceuticals (CASI) United States $0.320B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.303B 0.00
Karyopharm Therapeutics (KPTI) United States $0.292B 0.00
Minerva Neurosciences (NERV) United States $0.284B 0.00
Aclaris Therapeutics (ACRS) United States $0.282B 0.00
Lannett Co Inc (LCI) United States $0.281B 2.61
Harpoon Therapy (HARP) United States $0.273B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.267B 9.90
Xeris Pharmaceuticals (XERS) United States $0.257B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.246B 0.00
Molecular Templates (MTEM) United States $0.245B 0.00
Dova Pharmaceuticals (DOVA) United States $0.240B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.240B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.237B 0.00
Calithera Biosciences (CALA) United States $0.237B 0.00
Concert Pharmaceuticals (CNCE) United States $0.233B 0.00
Rafael Holdings (RFL) United States $0.225B 0.00
Aldeyra Therapeutics (ALDX) United States $0.224B 0.00
MEI Pharma (MEIP) United States $0.219B 0.00
Galectin Therapeutics (GALT) United States $0.216B 0.00
Opexa Therapeutics (ACER) United States $0.208B 0.00
Ardelyx (ARDX) United States $0.208B 0.00
Affimed (AFMD) Germany $0.207B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.202B 0.00
Majesco Entertainment (PTE) United States $0.196B 0.00
Recro Pharma (REPH) United States $0.185B 0.00
Jounce Therapeutics (JNCE) United States $0.184B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.184B 0.00
ElectroCore (ECOR) United States $0.180B 0.00
AgeX Therapeutics (AGE) United States $0.178B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 182.80
Foamix Pharmaceuticals (FOMX) Israel $0.175B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.171B 0.00
Ocular Therapeutix (OCUL) United States $0.171B 0.00
Neon Therapeutics (NTGN) United States $0.169B 0.00
Aratana Therapeutics (PETX) United States $0.168B 0.00
Tyme Technologies (TYME) United States $0.153B 0.00
IMV INC (IMV) Canada $0.149B 0.00
MediWound (MDWD) Israel $0.146B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Aquestive Therapeutics (AQST) United States $0.140B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.133B 0.00
ProNAi Therapeutics (SRRA) Canada $0.119B 0.00
Iterum Therapeutics (ITRM) Ireland $0.113B 0.00
Neos Therapeutics (NEOS) United States $0.111B 0.00
China SXT Pharmaceuticals (SXTC) China $0.109B 0.00
Cardiome Pharma (CORV) Canada $0.103B 0.00
Champions Oncology (CSBR) United States $0.102B 0.00
Natural Alternatives (NAII) United States $0.101B 9.83
Zafgen (ZFGN) United States $0.096B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.095B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.092B 0.00
Adherex Technologies (FENC) United States $0.092B 0.00
Nivalis Therapeutics (ALPN) United States $0.091B 0.00
DURECT (DRRX) United States $0.090B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.090B 0.00
Bio Blast Pharma (ENLV) Israel $0.089B 0.00
Infinity Pharmaceuticals (INFI) United States $0.088B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Avenue Therapeutics (ATXI) United States $0.083B 0.00
Otonomy (OTIC) United States $0.078B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.064B 0.00
Capnia (SLNO) United States $0.064B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.057B 0.00
Forward Pharma (FWP) Denmark $0.055B 0.00
Melinta Therapeutics (MLNT) United States $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.051B 0.00
India Globalization Capital (IGC) United States $0.050B 0.00
Bio-Path Holdings (BPTH) United States $0.046B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.046B 0.00
Lipocine (LPCN) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.044B 0.00
KemPharm (KMPH) United States $0.043B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.040B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
ContraFect (CFRX) United States $0.038B 0.00
Heat Biologics (HTBX) United States $0.036B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.034B 0.00
HANCOCK JAFFE (HJLI) United States $0.032B 0.00
IsoRay (ISR) United States $0.029B 0.00
Shineco (TYHT) China $0.029B 4.85
Achieve Life Sciences (ACHV) United States $0.027B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.027B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 3.47
PharmAthene (ALT) United States $0.025B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
NOVAN INC (NOVN) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Xenetic Biosciences (XBIO) United States $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
Trillium Therapeutics (TRIL) Canada $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.87
PRECISION THERAPEUTICS INC (AIPT) United States $0.011B 0.00
Can-Fite Biopharma (CANF) Israel $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Achaogen (AKAO) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00